BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/11/2022 8:36:00 AM | Browse: 813 | Download: 2144
Publication Name World Journal of Clinical Cases
Manuscript ID 72847
Country United States
Received
2021-10-30 18:28
Peer-Review Started
2021-10-30 18:29
First Decision by Editorial Office Director
2021-11-29 20:45
Return for Revision
2021-11-30 03:57
Revised
2021-12-16 04:14
Publication Fee Transferred
Editorial Processing by Scientific Editor
2022-06-01 02:58
Final Academic Decision by Editor-in-Chief
Publication Technical Verification by Editorial Office Director
2022-06-03 21:24
Articles in Press
2022-06-03 21:24
Edit the Manuscript by Language Editor
Typeset the Manuscript
2022-07-02 10:46
Publish the Manuscript Online
2022-07-11 08:36
ISSN 2307-8960 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/.
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Minireviews
Article Title Apheresis: A cell-based therapeutic tool for the inflammatory bowel disease
Manuscript Source Invited Manuscript
All Author List Farah Yasmin, Hala Najeeb, Unaiza Naeem, Abdul Moeed, Thoyaja Koritala and Salim Surani
ORCID
Author(s) ORCID Number
Farah Yasmin http://orcid.org/0000-0002-5264-6140
Hala Najeeb http://orcid.org/0000-0001-7075-4674
Unaiza Naeem http://orcid.org/0000-0002-0455-7864
Abdul Moeed http://orcid.org/0000-0003-4429-1391
Thoyaja Koritala http://orcid.org/0000-0002-1020-9882
Salim Surani http://orcid.org/0000-0001-7105-4266
Funding Agency and Grant Number
Corresponding Author Salim Surani, FACP, FCCP, MD, MSc, Doctor, Doctor, Professor, Medicine, Texas A&M University, 400 Bizzell St, , College Station, Texas 77843, United States. srsurani@hotmail.com
Key Words Inflammatory bowel disease; Apheresis; Granulocyte–monocyte-apheresis; Leukocytapheresis; TNF-α; Ulcerative colitis; Crohn’s disease
Core Tip Granulocyte–monocyte-apheresis (GMA) and leukocytapheresis (LCAP) present as safe and viable alternatives to the conventional treatment of inflammatory bowel disease (IBD). This review summarizes the mechanism and the evidence of the efficacy of the techniques in Ulcerative Colitis (UC) and Crohn’s Disease patients. The study's key findings include a commentary on special IBD patients, the unavailability of empirical evidence of reported adverse events of GMA or LCAP in the vulnerable population, such as pregnant women. It also focuses on GMA’s unknown safety in UC patients and the barriers encountered in GMA or LCAP trials.
Publish Date 2022-07-11 08:36
Citation Yasmin F, Najeeb H, Naeem U, Moeed A, Koritala T, Surani S. Apheresis: A cell-based therapeutic tool for the inflammatory bowel disease. World J Clin Cases 2022; 10(21): 7195-7208
URL https://www.wjgnet.com/2307-8960/full/v10/i21/7195.htm
DOI https://dx.doi.org/10.12998/wjcc.v10.i21.7195
Full Article (PDF) WJCC-10-7195.pdf
Full Article (Word) WJCC-10-7195.docx